🇺🇸 Hexalen in United States

FDA authorised Hexalen on 26 December 1990

Marketing authorisations

FDA — authorised 26 December 1990

  • Application: NDA019926
  • Marketing authorisation holder: EISAI INC
  • Local brand name: HEXALEN
  • Indication: CAPSULE — ORAL
  • Status: approved

Read official source →

FDA

  • Status: approved

Hexalen in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in United States

Frequently asked questions

Is Hexalen approved in United States?

Yes. FDA authorised it on 26 December 1990; FDA has authorised it.

Who is the marketing authorisation holder for Hexalen in United States?

EISAI INC holds the US marketing authorisation.